Isatuximab

Therapeutic indications

Isatuximab is indicated for:

Multiple myeloma

Population group: only adults (18 years old or older)

Isatuximab is indicated:

in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on the last therapy.
in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

10 mg/kg body weight weekly during cycle 1 and every 2 weeks during cycle 2 and beyond

Contraindications

Isatuximab is contraindicated in the following cases:

Pregnancy

< Previous: Overview

Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.